161 related articles for article (PubMed ID: 29566036)
1. The Brazilian version of Skindex-16 is a valid and reliable instrument to assess the health-related quality of life of patients with skin diseases.
Cárcano CBM; de Oliveira CZ; Paiva BSR; Paiva CE
PLoS One; 2018; 13(3):e0194492. PubMed ID: 29566036
[TBL] [Abstract][Full Text] [Related]
2. Translation and Validation of the Serbian Version of the Skindex-29 Instrument for Measuring Impact of Skin Disease on Quality of Life.
Milutinović JD; Krstić N; Janković SM
Acta Dermatovenerol Croat; 2017 Jul; 25(2):120-127. PubMed ID: 28871926
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Skindex-29 Questionnaire: Portuguese Version (Portugal).
Carvalho D; Aguiar P; Palma-Carlos A
Acta Med Port; 2018 Sep; 31(9):463-469. PubMed ID: 30332369
[TBL] [Abstract][Full Text] [Related]
4. Translation, cultural adaptation, and validation of the American Skindex-29 quality of life index.
Paula HR; Haddad A; Weiss MA; Dini GM; Ferreira LM
An Bras Dermatol; 2014; 89(4):600-7. PubMed ID: 25054747
[TBL] [Abstract][Full Text] [Related]
5. Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16.
He Z; Lu C; Chren MM; Zhang Z; Li Y; Ni X; Buchtel V HA; Ryan PF; Li GZ
Health Qual Life Outcomes; 2014 Dec; 12():190. PubMed ID: 25539748
[TBL] [Abstract][Full Text] [Related]
6. The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases.
Higaki Y; Kawamoto K; Kamo T; Horikawa N; Kawashima M; Chren MM
J Dermatol; 2002 Nov; 29(11):693-8. PubMed ID: 12484430
[TBL] [Abstract][Full Text] [Related]
7. Psychometric characteristics of DLQI-BRA and Skindex-16 to measure the impact of dermatological diseases on quality of life in Brazilian patients.
Meneguin S; de Souza Matos TD; Pollo CF; Garuzi M; Miot HA; de Oliveira C
PLoS One; 2021; 16(8):e0254882. PubMed ID: 34388159
[TBL] [Abstract][Full Text] [Related]
8. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases.
Chren MM; Lasek RJ; Sahay AP; Sands LP
J Cutan Med Surg; 2001; 5(2):105-10. PubMed ID: 11443481
[TBL] [Abstract][Full Text] [Related]
9. Arabic version of Skindex-16: translation and cultural adaptation, with assessment of reliability and validity.
AlGhamdi KM; AlShammari SA
Int J Dermatol; 2007 Mar; 46(3):247-52. PubMed ID: 17343578
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Skindex-16 questionnaire in patients with skin diseases in Morocco.
El Fakir S; Baybay H; Bendahhou K; Obtel M; Benchat L; Mernissi FZ; Nejjari C
J Dermatolog Treat; 2014 Apr; 25(2):106-9. PubMed ID: 22455447
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Skindex-17 quality of life assessment instrument for a Brazilian population.
Jorge MFS; Mourão IB; Pollo CF; Sousa TD; Meneguin S; Miot HA
An Bras Dermatol; 2021; 96(1):51-58. PubMed ID: 33281012
[TBL] [Abstract][Full Text] [Related]
12. Construct validity and responsiveness of the Colombian version of Skindex-29.
Vasquez D; Aguirre DC; Sanclemente G
Br J Dermatol; 2019 Oct; 181(4):770-777. PubMed ID: 30729508
[TBL] [Abstract][Full Text] [Related]
13. Turkish version of Skindex-29.
Aksu AE; Urer MS; Sabuncu I; Saracoglu ZN; Chren MM
Int J Dermatol; 2007 Apr; 46(4):350-5. PubMed ID: 17442071
[TBL] [Abstract][Full Text] [Related]
14. [The French version of Skindex (Skindex-France). Adaptation and assessment of psychometric properties].
Leplège A; Ecosse E; Zeller J; Revuz J; Wolkenstein P
Ann Dermatol Venereol; 2003 Feb; 130(2 Pt 1):177-83. PubMed ID: 12671579
[TBL] [Abstract][Full Text] [Related]
15. The Spanish version of Skindex-29.
Jones-Caballero M; Peñas PF; García-Díez A; Badía X; Chren MM
Int J Dermatol; 2000 Dec; 39(12):907-12. PubMed ID: 11168659
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Persian version of Skindex-16 among older patients with skin diseases.
Mahdavi Nejad T; Mohammadi F; Gorgulu O; Motalebi SA; Hosseinkhani Z
BMC Geriatr; 2021 Dec; 21(1):724. PubMed ID: 34922470
[TBL] [Abstract][Full Text] [Related]
17. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases.
Chren MM; Lasek RJ; Flocke SA; Zyzanski SJ
Arch Dermatol; 1997 Nov; 133(11):1433-40. PubMed ID: 9371029
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease.
Smidt AC; Lai JS; Cella D; Patel S; Mancini AJ; Chamlin SL
Arch Dermatol; 2010 Aug; 146(8):865-9. PubMed ID: 20713817
[TBL] [Abstract][Full Text] [Related]
19. Conceptualization, development and validation of T-QoL
Basra MKA; Salek MS; Fenech D; Finlay AY
Br J Dermatol; 2018 Jan; 178(1):161-175. PubMed ID: 28762236
[TBL] [Abstract][Full Text] [Related]
20. Validation of an Egyptian Arabic Version of Skindex-16 and Quality of Life Measurement in Egyptian Patients with Skin Disease.
Essa N; Awad S; Nashaat M
Int J Behav Med; 2018 Apr; 25(2):243-251. PubMed ID: 28748378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
